Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
retinoic acid receptor alpha | 0.470 | 0.846 | 0.96 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
thyroid hormone receptor alpha | 0.566 | 0.769 | 0.33 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
nuclear receptor subfamily 1 group D member 1 | 0.608 | 0.692 | 0.82 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.800 | strong | 0.948 | 679 | 15 | 1994 | 2020 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.700 | strong | 1.000 | 21 | 1 | 1994 | 2019 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.700 | strong | 0.900 | 20 | 3 | 1994 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.390 | None | 1.000 | 10 | 0 | 1994 | 2017 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
disease | 0.690 | limited | 1.000 | 10 | 1 | 1994 | 2017 | ||||||||
|
kinase insert domain receptor | 0.378 | 0.885 | 1.00 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1994 | 2019 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.360 | None | 1.000 | 6 | 5 | 1994 | 2019 | ||||||||
|
filamin A interacting protein 1 like | 0.705 | 0.500 | 1.1E-09 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1994 | 2017 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 1994 | 2019 | ||||||||
|
DAB adaptor protein 2 | 0.565 | 0.731 | 0.41 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 1994 | 2017 | ||||||||
|
bromodomain containing 2 | 0.450 | 0.808 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1994 | 2018 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 1994 | 2014 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1994 | 2019 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1994 | 2018 | |||||||||
|
double C2 domain alpha | 0.700 | 0.385 | 6.7E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1994 | 2001 | ||||||||
|
anaphase promoting complex subunit 10 | 0.780 | 0.308 | 5.5E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
dual specificity phosphatase 3 | 0.705 | 0.308 | 0.46 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
keratin 9 | 0.678 | 0.346 | 1.1E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
NME1-NME2 readthrough | 0.623 | 0.615 | 8.8E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
cyclin dependent kinase 2 associated protein 1 | 0.656 | 0.538 | 0.45 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
myopalladin | 0.612 | 0.615 | 2.6E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 |